Marshall Wace North America L.P. - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 153 filers reported holding THERAPEUTICSMD INC in Q3 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q2 2021$601,000
-25.8%
505,297
-16.4%
0.00%0.0%
Q1 2021$810,000
-26.1%
604,240
-33.3%
0.00%
-40.0%
Q4 2020$1,096,000
-48.6%
905,416
-33.0%
0.01%
-64.3%
Q3 2020$2,134,000
+134.5%
1,350,597
+85.4%
0.01%
+133.3%
Q2 2020$910,000
-65.2%
728,335
-32.6%
0.01%
-53.8%
Q4 2019$2,615,000
+4834.0%
1,080,694
+7728.3%
0.01%
+1200.0%
Q4 2018$53,00013,8050.00%
Other shareholders
THERAPEUTICSMD INC shareholders Q3 2021
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 1,575,000$10,080,0000.84%
MORGENS WATERFALL VINTIADIS & CO INC 180,000$1,152,0000.80%
GILDER GAGNON HOWE & CO LLC 5,045,685$32,292,0000.63%
EAM Investors, LLC 508,483$3,254,0000.51%
STONERIDGE INVESTMENT PARTNERS LLC 468,986$3,002,0000.44%
1492 Capital Management LLC 41,132$263,0000.22%
HEARTLAND ADVISORS INC 600,000$3,840,0000.20%
OUTFITTER ADVISORS, LTD. 63,532$407,0000.16%
Piermont Capital Management Inc. 66,240$424,0000.14%
GAM Holding AG 1,202,729$7,697,0000.13%
View complete list of THERAPEUTICSMD INC shareholders